<DOC>
	<DOCNO>NCT00617643</DOCNO>
	<brief_summary>Triomune commonly prescribe treatment HIV infection Uganda . Triomune manufacture generic drug company consist three drug combine single pill give twice daily ( stavudine 30mg plus lamivudine 150mg plus nevirapine 200mg ) . It known level nevirapine patient 's blood high first two week treatment . Therefore recommend patient start nevirapine undergo dose escalation i.e start 200mg daily two week increase full dose 200mg twice daily order avoid nevirapine related rash . It possible dose escalation fix dose combination pill like Triomune two week dose escalation patient either buy stavudine plus lamivudine plus nevirapine separate pill take Triomune morning take stavudine plus lamivudine separate pill even . Rifampicin use treat TB lower level nevirapine patient 's blood . This raise two question routine clinical practice patient co-infected HIV TB ( 1 ) Do need put patient trouble dose escalation nevirapine already rifampicin ? ( 2 ) If dose escalate nevirapine patient rifampicin , put risk low drug level development resistance ? The aim study compare plasma concentration nevirapine HIV infect patient commence antiretroviral therapy without lead dose nevirapine also receive concomitant treatment antituberculous therapy include rifampicin ass whether dose escalation nevirapine appropriate patient population</brief_summary>
	<brief_title>Nevirapine Drug Levels HIV Positive Patients Also Receiving Rifampicin Tuberculosis</brief_title>
	<detailed_description>Many patient Uganda co-infected HIV TB require simultaneous treatment disease . There paucity data complex pharmacokinetic interaction antiretroviral anti-TB drug available data representative African setting , hence important complex drug interaction characterize fully . Rifampicin potent inducer several liver intestinal enzyme responsible drug metabolism include cytochrome P450 ( CYP450 ) system , p-glycoprotein ( PgP , multi-drug resistant transport protein ) . The non-nucleoside reverse transcriptase inhibitor ( NNRTIs ) nevirapine lipophilic drug undergo passive diffusion gastrointestinal lining . Once inside intestinal cell drug transport back luminal surface PgP oxidatively metabolise CYP450 enzyme . Thus induction CYP450 PgP rifampicin result accelerate extensive presystemic metabolism NNRTI substrates result decreased oral bioavailability . Available data suggest rifampicin reduces AUC NNRTI , nevirapine 31 % Cmin 21 % 68 % ( Ribera 2001 , Robinson 1998 ) respectively . While minor reduction level nucleoside reverse transcriptase inhibitor ( NRTI ) , zidovudine report ( probably due increase glucuronidation ; ( Burger 1993 ) , generally agree efficacy NRTIs affect concomitant rifampicin use . Nevirapine , dipyridodiazepinone , inducer cytochrome P450 also induce metabolism reduction elimination half life 45 25 hour repeat dose ( Havlir , Murphy ) . The recommended daily dose regimen nevirapine adult 200mg twice daily . This precede two week lead dose 200mg daily autoinduction nevirapine hepatic metabolism . This dose escalation strategy reduce nevirapine related rash 48 % ( absence dose escalation ) 18 % . ( Murphy ) . Dose escalation nevirapine complex resource limit set fix dose combination generically manufacture drug commonly prescribe . It unclear whether dose escalation nevirapine necessary patient rifampicin already full induction cytochrome P450 system provide rifampicin minimum two week . Furthermore , concern dose escalation nevirapine group patient may expose patient sub-therapeutic level nevirapine attendant risk development drug resistance .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Ability provide full inform write consent Confirmed diagnosis HIV infection On rifampicin therapy least two week Clinical criterion commence antiretroviral therapy Hemoglobin &lt; 8g/dl Liver renal function test &gt; 3 time upper limit normal Pregnancy Use know inhibitor inducer Cytochrome P450 Pglycoprotein . Use herbal medication Intercurrent Illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Nevirapine</keyword>
	<keyword>Rifampicin</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>